AWAP
ABBV icon

Alliance Wealth Advisors (Pennsylvania)’s AbbVie ABBV Stock Holding History

Alliance Wealth Advisors (Pennsylvania)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Sell
4,644
-394
-8% -$84.8K 0.38% 40
2026
Q1 		$1.1M Hold
5,038
– – 0.48% 39
2025
Q4 		$1.15M Buy
5,038
+1
+0% +$228 0.5% 36
2025
Q3 		$1.17M Sell
5,037
-62
-1% -$12.6K 0.52% 34
2025
Q2 		$947K Buy
5,099
+57
+1% +$10.6K 0.48% 36
2025
Q1 		$1.06M Sell
5,042
-58
-1% -$11.3K 0.6% 31
2024
Q4 		$906K Hold
5,100
– – 0.51% 36
2024
Q3 		$1.01M Buy
5,100
+115
+2% +$21.5K 0.58% 36
2024
Q2 		$855K Sell
4,985
-70
-1% -$11.6K 0.54% 36
2024
Q1 		$921K Sell
5,055
-212
-4% -$36.5K 0.58% 34
2023
Q4 		$816K Buy
5,267
+1
+0% +$146 0.54% 35
2023
Q3 		$785K Hold
5,266
– – 0.57% 37
2023
Q2 		$709K Sell
5,266
-439
-8% -$64.4K 0.5% 42
2023
Q1 		$909K Sell
5,705
-36
-0.6% -$5.5K 0.68% 32
2022
Q4 		$928K Sell
5,741
-383
-6% -$58.7K 0.77% 30
2022
Q3 		$822K Sell
6,124
-142
-2% -$20.4K 0.77% 31
2022
Q2 		$960K Sell
6,266
-485
-7% -$74.1K 0.83% 30
2022
Q1 		$1.09M Sell
6,751
-388
-5% -$56.4K 0.91% 29
2021
Q4 		$967K Buy
7,139
+201
+3% +$23.7K 0.79% 33
2021
Q3 		$748K Buy
6,938
+161
+2% +$18.4K 0.66% 38
2021
Q2 		$763K Sell
6,777
-109
-2% -$12.3K 0.69% 35
2021
Q1 		$745K Sell
6,886
-13,972
-67% -$1.49M 0.74% 35
2020
Q4 		$2.23M Buy
+20,858
New +$2M 2.35% 13

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Alliance Wealth Advisors (Pennsylvania)'s ABBV Position: Q2 2026 in Review

Alliance Wealth Advisors (Pennsylvania) reduced its AbbVie (ABBV) stake by 7.8% in Q2 2026, selling an estimated $84.8K and leaving 4,644 shares worth $1.17M. The position accounts for 0.38% of the portfolio, ranked #40.

Alliance Wealth Advisors (Pennsylvania) first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.23M in Q4 2020. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Alliance Wealth Advisors (Pennsylvania) held 4,644 shares of AbbVie worth $1.17M as of Q2 2026.
  • Alliance Wealth Advisors (Pennsylvania) sold 394 AbbVie shares in Q2 2026, an estimated $84.8K.
  • AbbVie made up 0.38% of Alliance Wealth Advisors (Pennsylvania)'s portfolio in Q2 2026, its #40 holding.
  • Alliance Wealth Advisors (Pennsylvania) first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Alliance Wealth Advisors (Pennsylvania)'s AbbVie position peaked at $2.23M in Q4 2020.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Alliance Wealth Advisors (Pennsylvania)'s 13F filing for Q2 2026, filed 9 Jul 2026.